Polypharmacy

Open Access
Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
Carole E. Aubert, Manuel R. Blum, Viktoria Gastens, Olivia Dalleur, Fanny Vaillant, Emma Jennings, Drahomir Aujesky, Wade Thompson, Tijn Kool, Cornelius Kramers, Wilma Knol, Denis O’Mahony and Nicolas Rodondi

February 28, 2023 11 (1) E170-E178; DOI: https://doi.org/10.9778/cmajo.20210240
Open Access
Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trial
Jerome Williams, Marc-Alexandre Gingras, Robert Dubé, Todd C. Lee and Emily G. McDonald

July 12, 2022 10 (3) E652-E656; DOI: https://doi.org/10.9778/cmajo.20210302
Open Access
Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study
Jeremy Y. Ng, Kevin Gilotra, Sana Usman, Yaping Chang and Jason W. Busse

April 13, 2021 9 (2) E342-E348; DOI: https://doi.org/10.9778/cmajo.20200187
You have access
Characteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis
Mina Tadrous, Diana Martins, Muhammad M. Mamdani and Tara Gomes

April 28, 2020 8 (2) E297-E303; DOI: https://doi.org/10.9778/cmajo.20190231
You have access
Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study
Martin Dawes, Martin N. Aloise, J. Sidney Ang, Pieter Cullis, Diana Dawes, Robert Fraser, Gideon Liknaitzky, Andrea Paterson, Paul Stanley, Adriana Suarez-Gonzalez and Hagit Katzov-Eckert

September 22, 2016 4 (3) E528-E534; DOI: https://doi.org/10.9778/cmajo.20150070

Main menu

User menu

Search

Polypharmacy

Content

Authors & Reviewers

About